UNSPSC 51183405: Mitiglinide calcium

This classification denotes an anti-diabetic agent with the molecular formula 2C19H24NO3.Ca, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P5WOR98G68, chemically known as (s)-2-benzyl-4-oxo-4-(cis-perhydroisoindol-2-yl)butyric acid calcium salt, but more generally known as mitiglinide calcium, which bears US NIH Compound Identifier 5478927. European Medicines Agency schedules mitiglinide calcium or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08999MIG.

Most nations, for tariff purposes, schedule mitiglinide calcium under HS 29339990. SMILES: C1CCC(CC1)C[C@@H](CC(=O)N2C[C@H]3CCCC[C@H]3C2)C(=O)[O-].C1CCC(CC1)C[C@@H](CC(=O)N2C[C@H]3CCCC[C@H]3C2)C(=O)[O-].[CA+2].

UNSPSC 51183405 Mitiglinide calcium, a Commodity code, covers the procurement of this rapid-acting insulin secretagogue medication used in diabetes management. State and local governments buy mitiglinide calcium primarily through health departments, correctional facilities, public hospitals, and medicaid agencies to support inmate healthcare, emergency department operations, and beneficiary pharmaceutical programs. The medication is typically procured via competitive bidding or cooperative purchasing agreements that establish unit pricing and delivery terms, often as part of broader pharmacy formulary buys or disease-state management contracts rather than as standalone line items.

The source provides no recent state or local contract opportunities tagged to this code, making current market activity assessment impossible. Without posted solicitations, response dates, issuing-body patterns, or geographic concentration data, firms evaluating this code cannot determine procurement velocity, buyer jurisdictions, or tender timing. Verify activity directly with state medicaid procurement offices, county health departments, and public hospital systems in target regions, or monitor cooperative purchasing catalogs (such as those administered by state purchasing consortia) for formulary bid cycles that may include this commodity.